Clinical trial · Interventional
NEXT (Nutrition and EXercise During Adjuvant Treatment) Study
Nutrition and Exercise During Adjuvant Treatment (NEXT) Study Implementation of a Physician-referred Exercise and Healthy Eating Intervention as Supportive Care in Breast Cancer Survivors
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study will offer a supervised exercise program and healthy eating education to women with breast cancer undergoing chemotherapy as a physician-referred program and measure the adoption, adherence and satisfaction with the intervention as well as its health effects. Past trials have demonstrated various health benefits of exercise yet it is not currently part of supportive care and few suitable programs exist in the community or outside of research. This study is expected to address the unique barriers related to exercise in breast cancer survivors and to better understand how the intervention might work in a real life setting.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Exercise | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- Cancer Treatment
- interventionNames
- Other: Exercise
Primary outcomes (1)
- measure
- The primary outcome will report as recruitment, retention and adherence rates for the sample and their associated 95% confidence intervals
- timeFrame
- 2 years
Secondary outcomes (1)
- measure
- Means and standard deviations
- timeFrame
- 2 years
- description
- The secondary outcomes will be will be summarized with means and standard deviations for normally distributed data and assessed by repeated measures ANOVA to examine change over time
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 19 Years
Show eligibility criteria text
Inclusion Criteria: * female; * aged 19 years and older; * newly diagnosed with early stage (I-IIIA) breast cancer; * prescribed adjuvant chemotherapy (with or without radiation) as part of curative treatment for breast cancer; and * good comprehension of English Exclusion Criteria: * contraindications for entry into an exercise program (i.e., known cardiovascular disease, uncontrolled diabetes mellitus, or musculoskeletal impairment issue); * body mass index (BMI) \>40 (morbid obesity); * mobility impairment requiring use of mobility aids; * stage IV cancer * metastatic disease * neo-adjuvant chemotherapy (with likelihood of surgery after chemotherapy) Gender exclusion criteria: Male breast cancer is excluded as it is a rare diagnosis. Age exclusion criteria: Based on enrolling adult participants only. Language exclusion criteria: A good comprehension of English is required to receive instruction on the intervention and complete study forms and evaluations.
References
Publications (0)
Data not yet available